Fig. 1From: Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective studyPharmacokinetic profiles of gefitinib (a, c) and O-desmethyl gefitinib (b, d) in elderly patients with NSCLC. N = 18. a and b depict the individual plasma concentration profiles of gefitinib and O-desmethyl gefitinib, respectively. c and d represent the average plasma concentration profiles of gefitinib and O-desmethyl gefitinib, respectively. Each data point indicates the mean ± SD. NSCLC non-small cell lung cancer, SD standard deviationBack to article page